Chemed Corporation CHE
512.16
16.51
3.33%
as of 25 Sep
- Market cap
- $6.5B
- P/E
- 25.7×
Follow CHE
Growth Flags
show if company had growth for consecutive years
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 27.11% | 25.60% | 25.28% | 24.11% |
+8 more TTM periods Free account |
|
| 16.68% | 15.93% | 16.54% | 16.43% | ||
ROIC |
23.46% | 22.23% | 23.36% | 23.20% | |
Return on Tangible Assets |
152.87% | 161.98% | 119.94% | 90.77% | |
Average Days of Receivables |
26.53 | 30.96 | 26.34 | 31.09 | |
Free Cash Flow per Share |
24.91 | 27.91 | 22.92 | 25.32 | |
Free Cash Flow |
328.12 | 381.71 | 330.05 | 364.45 | |
Capital Expenditures |
(61.84) | (62.04) | (58.23) | (55.20) | |
Piotroski F-Score |
4.00 | 4.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
38.58% | 46.41% | 36.84% | 34.78% | |
Accounts Receivable Turnover |
13.90 | 10.13 | 14.30 | 12.28 | |
Accounts Payable Turnover |
25.60 | 30.30 | 31.43 | 36.51 | |
Inventory Turnover |
206.90 | 229.10 | 216.93 | 187.30 | |
Average Days of Payables |
17.81 | 13.96 | 13.78 | 10.34 | |
Days of Inventory on Hand |
1.60 | 1.53 | 1.61 | 1.77 | |
Tax Rate |
(0.26) | (0.26) | (0.25) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.99% | 16.76% | 16.49% | 16.44% | |
Share Based Compensation of Revenue |
1.46% | 1.44% | 1.48% | 1.52% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
1.42 | 1.71 | 1.46 | 1.51 | |
Depreciation/Fixed assets |
0.32 | 0.32 | 0.32 | 0.32 | |
Capex/Depreciation |
(0.93) | (0.94) | (0.89) | (0.85) | |
Revenue per Share |
196.98 | 185.78 | 175.72 | 175.81 | |
Operating CF per Share |
29.60 | 32.45 | 26.97 | 29.15 | |
Capex per Share |
(4.69) | (4.54) | (4.04) | (3.84) | |
Capex to Sales |
0.02 | 0.02 | 0.02 | 0.02 | |
Net Profit Margin |
10.60% | 10.23% | 10.48% | 11.02% |
Columns are period end dates